Humana Inc. $HUM Shares Acquired by 180 Wealth Advisors LLC

180 Wealth Advisors LLC lifted its holdings in shares of Humana Inc. (NYSE:HUMFree Report) by 179.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,893 shares of the insurance provider’s stock after acquiring an additional 2,498 shares during the period. 180 Wealth Advisors LLC’s holdings in Humana were worth $675,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Long Focus Capital Management LLC acquired a new position in shares of Humana in the 3rd quarter valued at $34,212,000. Aberdeen Group plc raised its stake in Humana by 18.1% during the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock worth $72,684,000 after acquiring an additional 43,442 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in Humana by 4.1% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after acquiring an additional 9,960 shares during the last quarter. Ninety One UK Ltd lifted its position in Humana by 57.2% in the fourth quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock valued at $28,815,000 after acquiring an additional 40,958 shares during the last quarter. Finally, Sustainable Insight Capital Management LLC boosted its stake in Humana by 23.7% in the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock valued at $6,341,000 after acquiring an additional 4,740 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on HUM. Needham & Company LLC started coverage on Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock. Sanford C. Bernstein reissued an “outperform” rating and issued a $425.00 target price on shares of Humana in a research report on Wednesday, June 3rd. Seaport Research Partners downgraded Humana to a “neutral” rating in a research note on Wednesday, May 20th. Wolfe Research raised Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Finally, TD Cowen boosted their price objective on Humana from $173.00 to $211.00 and gave the company a “hold” rating in a research note on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $303.74.

Check Out Our Latest Stock Report on Humana

Humana Stock Performance

Shares of HUM stock opened at $392.76 on Monday. The stock’s 50-day moving average price is $338.80 and its 200 day moving average price is $255.17. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $47.15 billion, a PE ratio of 42.01, a price-to-earnings-growth ratio of 2.24 and a beta of 0.71. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $415.00.

Humana (NYSE:HUMGet Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same period last year, the firm earned $11.58 EPS. The firm’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities research analysts forecast that Humana Inc. will post 9.03 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s dividend payout ratio (DPR) is currently 37.86%.

Humana Company Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.